RxDoctor Payments Data

Amy Browne, DO

Family Medicine · Norwalk, OHNPI 1184819351

Payments from drug & device makers

$5,355in general payments, 2019–2025

Across 320 payments — averaging $16.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$681
  • Novo Nordisk$543
  • Pfizer$543
  • Lilly USA, LLC$456
  • Bayer$316
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$5,355100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,355 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$47,549
Medicare patients
215
Services billed
903

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide78$91,077
OzempicSemaglutide84$86,504
EliquisApixaban47$47,945
JanuviaSitagliptin Phosphate55$42,820
RybelsusSemaglutide24$29,785
JardianceEmpagliflozin33$27,596
KerendiaFinerenone31$26,641
XareltoRivaroxaban20$25,365
FarxigaDapagliflozin Propanediol35$25,192
TradjentaLinagliptin36$24,695
Breztri AerosphereBudesonide/Glycopyr/Formoterol36$23,644
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$20,845
Tresiba Flextouch U-200Insulin Degludec11$19,769
Tresiba Flextouch U-100Insulin Degludec39$18,744
Lantus SolostarInsulin Glargine,hum.Rec.Anlog73$17,845

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$543$116,289108 claims
Lilly USA, LLCMounjaro, Trulicity$456$102,82889 claims
MerckJanuvia, Janumet Xr, Belsomra, Dulera$93$69,86297 claims
Boehringer IngelheimJardiance, Tradjenta$86$52,29169 claims
AstraZenecaFarxiga, Breztri Aerosphere$681$48,83671 claims
PfizerEliquis$543$47,94547 claims
GSKTrelegy Ellipta, Breo Ellipta$78$29,67549 claims
BayerKerendia$316$26,64131 claims
Johnson & JohnsonXarelto$155$25,36520 claims
Astellas Pharma US IncMyrbetriq$43$15,49525 claims
AbbVieSynthroid$1,036$1,99363 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Norwalk

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →